MedTrace Logo

Reducing Circulating Sphingolipid Levels to Optimise Cardiometabolic Health - The SphingoFIT Trial

NCT06024291 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2025-05-15

No results posted yet for this study

Summary

The purpose of this study is to assess the effects of an 8-week supervised high-intensity interval training (HIIT) program (vs. physical activity recommendations according to current guidelines) on a comprehensive panel of circulating sphingolipids in middle-aged females and males at elevated cardiometabolic risk.

Conditions

Interventions

OTHER

8-week HIIT programme

See arm description

OTHER

Physical activity recommendation

See arm description

Sponsors & Collaborators

  • University of Lausanne

    collaborator OTHER

  • Technical University of Munich

    collaborator OTHER

  • University of Basel

    lead OTHER

Principal Investigators

  • Arno Schmidt-Trucksäss, Prof, MD, MA · Department of Sport, Exercise and Health, University of Basel, Basel, Switzerland

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-15
Primary Completion
2025-01-15
Completion
2025-01-15

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06024291 on ClinicalTrials.gov